# Etoposide

## Fytosid inj 100mg/5mL

##### 臨採

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                  |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | IFYT                                                                                                                                                                                                                                                                                                                                                                                  |
| 適應症     | Small cell carcinoma of lung, In combination with other approved chemotherapeutic agents as first line, Testicular cancer, In combination with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy                                                    |
| 用法用量   | [Testicular cancer (combination chemotherapy)] Usual dose ranges from 50-100 mg/m2/day on days 1 through 5 to 100 mg/m2/day on days 1, 3 and 5. [Small cell lung cancer (combination chemotherapy)] Usual dose ranges from 35 mg/m2/day for 4 days to 50 mg/m2/day for 5 days. Chemotherapy courses are repeated at 3- to 4-week intervals after adequate recovery from any toxicity. |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                          |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                            |
| 禁忌       | Hypersensitivity to etoposide or any component of the formulation. Severe leukopenia or thrombocytopenia; severe hepatic impairment; severe renal impairment                                                                                                                                                                                                                          |
| 副作用     | Alopecia, Shivering, Diarrhea, Inflammatory disease of mucous membrane, Loss of appetite, Nausea, Vomiting, Asthenia, Fever, Malaise                                                                                                                                                                                                                                                  |
| 孕期建議   | No Data                                                                                                                                                                                                                                                                                                                                                                               |
| 哺乳期建議 | No (Limited) Human Data – Potential Toxicity(Mother) 無(很少)資料 – 避免使用(母體)                                                                                                                                                                                                                                                                                                    |

## Vepesid 50mg (專案進口)

##### 臨採

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | OVEP5                                                                                                                                                                                                                                                                                                                                                                                                     |
| 適應症     | Small cell carcinoma of lung, In combination with other approved chemotherapeutic agents as first line, Testicular cancer, In combination with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy                                                                        |
| 用法用量   | (無TFDA仿單) (US FDA仿單) [Testicular cancer] dose ranges from 50-100 mg/m2/day on days 1 through 5 to 100 mg/m2/day on days 1, 3, and 5 in combination with other approved chemotherapeutic agents. [Small cell lung cancer] dose ranges from 35 mg/m2/day for 4 days to 50 mg/m2/day for 5 days. Chemotherapy courses are repeated at 3- to 4-week intervals after adequate recovery from any toxicity. |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                |
| 禁忌       | Hypersensitivity to etoposide or any component of the formulation. Severe leukopenia or thrombocytopenia; severe hepatic impairment; severe renal impairment                                                                                                                                                                                                                                              |
| 副作用     | Alopecia, Shivering, Diarrhea, Inflammatory disease of mucous membrane, Loss of appetite, Nausea, Vomiting, Asthenia, Fever, Malaise                                                                                                                                                                                                                                                                      |
| 孕期建議   | No Data                                                                                                                                                                                                                                                                                                                                                                                                   |
| 哺乳期建議 | No (Limited) Human Data – Potential Toxicity(Mother) 無(很少)資料 – 避免使用(母體)                                                                                                                                                                                                                                                                                                                        |

